Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Wanglong Pharmaceutical Group is a leading Chinese pharmaceutical manufacturer specializing in Traditional Chinese Medicine (TCM) and a broad range of modern drug formulations. Headquartered in Houma, Shanxi Province, the company possesses over 100 drug approval certificates, including tablets, capsules, and granules focused on respiratory, cardiovascular, and digestive health. Its flagship products include well-known TCM remedies such as Cold and Heat Clearing Granules and Binglang Sixiao Wan, alongside nutritional supplements for bone and pediatric health. Wanglong Pharmaceutical operates integrated GMP-certified production bases and is recognized for its work in the industrialization of authentic Chinese medicinal herbs. As a major regional player, it serves both the clinical and over-the-counter (OTC) markets across China, playing a critical role in the regional pharmaceutical value chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wanglong Pharmaceutical.